Dermapharm AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Dermapharm AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013148
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dermapharm AG (Dermapharm) is a pharmaceutical company that offers dermatological and allergy medicines. The company provides products for allergies, disinfection and wound treatment, skin and hair care, corticoids, minerals, osteoporosis, fungal infections, vaginal thrush, other preparations, specific skincare, vein problems and vitamins, among others. It provides products in the form of retards, nail polish, creams, gels, hair and normal solutions, tablets, chewable tablets, OSH creams, shampoos, liquids, liquid pump sprays, powder, ointment and suspensions, among others. The company distributes its products through a network of distributors in domestic and overseas markets. Dermapharm is headquartered in Grunwald, Germany.

Dermapharm AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dermapharm AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Dermapharm AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Dermapharm AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Dermapharm AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Dermapharm AG, Medical Devices Deals, 2011 to YTD 2017 9
Dermapharm AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Dermapharm AG, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Dermapharm May Sell Itself 11
Acquisition 12
Dermapharm Rumored To Acquire Galenika 12
Dermapharm Acquires 95% Stake In Farmal, Generic Pharma Company 13
Dermapharm AG – Key Competitors 14
Dermapharm AG – Key Employees 15
Dermapharm AG – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Dermapharm AG, Pharmaceuticals & Healthcare, Key Facts 2
Dermapharm AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Dermapharm AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Dermapharm AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Dermapharm AG, Deals By Therapy Area, 2011 to YTD 2017 8
Dermapharm AG, Medical Devices Deals, 2011 to YTD 2017 9
Dermapharm AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Dermapharm May Sell Itself 11
Dermapharm Rumored To Acquire Galenika 12
Dermapharm Acquires 95% Stake In Farmal, Generic Pharma Company 13
Dermapharm AG, Key Competitors 14
Dermapharm AG, Key Employees 15
Dermapharm AG, Subsidiaries 16

★海外企業調査レポート[Dermapharm AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fenner PLC (FENR):企業の財務・戦略的SWOT分析
    Summary Fenner PLC (Fenner) a subsidiary of Michelin SCA, is a provider of reinforced polymer technology. The company operates in the areas of advanced engineered products and engineered conveyor solutions. Its product portfolio includes heavyweight conveyor belt, high performance polymer components …
  • Westinghouse Electric Company LLC-エネルギー分野:企業M&A・提携分析
    Summary Westinghouse Electric Company, LLC (Westinghouse), a subsidiary of Toshiba Corporation, is a nuclear energy company. It offers nuclear plant products, technologies, nuclear fuel, plant design and related services to utilities across the world. The company conducts the development, licensing, …
  • Fairfield Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Fairfield Energy Ltd (Fairfield Energy), a subsidiary of Decom Energy Ltd is an oil and gas company that offers oil and gas decommissioning services. The company acquires and develops hydrocarbon properties. It acquires and operates marginal fields in the UK continental shelf. Fairfield Ener …
  • Longfor Group Holdings Limited:企業の戦略・SWOT・財務情報
    Longfor Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Longfor Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Severoceske doly as:企業の戦略・SWOT・財務情報
    Severoceske doly as - Strategy, SWOT and Corporate Finance Report Summary Severoceske doly as - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • HOV Services Ltd (HOVS):企業の財務・戦略的SWOT分析
    HOV Services Ltd (HOVS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Japan Foods Co Ltd:企業の戦略・SWOT・財務分析
    Japan Foods Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Foods Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Milestone Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Milestone Pharmaceuticals Inc (Milestone Pharmaceuticals) is a cardiovascular drug development company that develops novel small molecule therapeutics. The company undertakes the development of small molecule therapeutics based on clinically validated mechanisms, for the treatment of cardiov …
  • Catalyst Paper Corporation:企業の戦略的SWOT分析
    Catalyst Paper Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Heidelberger Druckmaschinen AG (HDD):企業の財務・戦略的SWOT分析
    Heidelberger Druckmaschinen AG (HDD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Materialise NV (MTLS)-医療機器分野:企業M&A・提携分析
    Summary Materialise NV (Materialise) is a technology company that offers additive manufacturing software and 3D printing solutions. The company’s products comprise the factory for 3D printing, rapid Fit, solutions for machine developers, biomedical engineering software, software for additive manufac …
  • Parkway Properties Inc:企業のM&A・事業提携・投資動向
    Parkway Properties Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Parkway Properties Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Adacel Technologies Limited:企業の戦略・SWOT・財務情報
    Adacel Technologies Limited - Strategy, SWOT and Corporate Finance Report Summary Adacel Technologies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • DiscGenics Inc-製薬・医療分野:企業M&A・提携分析
    Summary DiscGenics Inc (DiscGenics) is a biotechnology company that develops advanced spinal therapeutics. The company develops therapies to treat patients with intervertebral disc diseases. Its products comprise Injectable Discogenic Cell Therapy (IDCT), developed for treating patients with moderat …
  • Laboratoires Pierre Fabre SA:企業の戦略的SWOT分析
    Laboratoires Pierre Fabre SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Calixar SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Calixar SAS (Calixar) is a provider of solutions to develop conformational antibodies. The company offers production, Solubilization, extraction, purification, stabilization and crystallization of functional membrane proteins and antigens. It offers technology to discover and validate the po …
  • Gibb River Diamonds Ltd (POZ):企業の財務・戦略的SWOT分析
    Summary Gibb River Diamonds Ltd , formerly POZ Minerals Ltd, is a mining and mineral exploration and development company. The company acquires, explores and develops diamond, phosphate and gold properties. Its projects include Blina Diamond project, Highland Plains Phosphate project and Laverton Gol …
  • Bristol-Myers Squibb Co (BMY):企業の財務・戦略的SWOT分析
    Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Covanta Holding Corporation
    Covanta Holding Corporation - Strategy, SWOT and Corporate Finance Report Summary Covanta Holding Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • IOOF Holdings Ltd (IFL):企業の財務・戦略的SWOT分析
    IOOF Holdings Ltd (IFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆